Načítá se...
In vivo activation of transferred regulatory T cells specific for third‐party exogenous antigen controls GVH disease in mice
Treg cells hold enormous promise for therapeutic application in GVH disease, a lethal complication of allogeneic HSC transplantation. Mouse studies showed that donor‐derived recipient‐specific Treg (rsTreg) cells are far more efficient than polyclonal Treg cells in suppressing GVH disease. However,...
Uloženo v:
| Vydáno v: | Eur J Immunol |
|---|---|
| Hlavní autoři: | , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
John Wiley and Sons Inc.
2013
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4738555/ https://ncbi.nlm.nih.gov/pubmed/23765389 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/eji.201343449 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|